期刊文献+

NDV7793促进人CD4^+T细胞表达TRAIL的实验研究 被引量:2

The Expression of TRAIL in Human CD4^+ T Cells Activated by NDV7793
下载PDF
导出
摘要 目的:研究新城疫病毒(Newcastle disease virus,NDV)弱毒株NDV7793能否促进人CD4+T细胞表达肿瘤坏死因子相关凋亡因子诱导配体(TNF-related apoptosis-inducing ligand,TRAIL)。方法:首先用免疫磁珠分选法(magnetic activated cell sorting,MACS)分选外周血静止CD4+T细胞,然后加抗CD3抗体、抗CD28抗体和白细胞介素-2(interleukin-2,IL-2)使之成为能被NDV激活的CD4+T细胞。用流式细胞技术(flow cytometry,FCM)检测NDV刺激的CD4+T细胞的TRAIL的表达水平。结果:MACS法分选外周血得到的CD4+T细胞纯度达到(97.38±0.28)%;能被NDV激活的CD4+T细胞表面分子CD25和CD69双阳性表达率可达(29.30±1.08)%,与PBS阴性对照组(2.40±1.30)%相比,差异有统计学意义(P<0.05);FCM检测结果显示,与对照组比较,NDV7793刺激的CD4+T细胞TRAIL表达水平均有显著升高,且在NDV7793效价为25 HU时达到最大值。结论:NDV7793可刺激CD3抗体、CD28抗体和IL-2预先活化的CD4+T细胞表达TRAIL。 Objective:To study the TRAIL up-regulation in human CD4+T cells which stimulated by NDV7793. Method:Pure CD4+T cells were isolated by using MACS. The CD4+T cells were pre-activated with anti-CD3/anti-CD28 antibodies and IL-2 at first. And then after pre-activated CD4+T cells were stimulated by NDV7793,the expression level of TRAIL was detected by FCM.Result:The purity of CD4+T cells was(97.38±0.28)%. The CD25,CD69 cells accounted for(29.30±1.08)%after activated which was higher than that(2.40±1.30)%of the negative control group. FCM results indicated,the expression of TRAIL increased significantly when CD4+T cells stimulated by NDV7793 compared with the control group,and reached the highest when NDV7793 at 25 HU.Conclusion:NDV7793 can up-regulate the expression of TRAIL and IFNγof pre-activated CD4+T cells.
出处 《中国医学创新》 CAS 2014年第9期1-3,共3页 Medical Innovation of China
基金 广西自然科学基金资助项目(2013GXNSFBA019160) 广西医学科学实验中心开放基金项目(KFJJ2011-21)
  • 相关文献

参考文献11

  • 1Aghi M, Martuza R L.Oneolytie viral therapies - the clinical experienee[J].Oneogene, 2005, 24 (52):7802-7816.
  • 2Chlichlia K, Schirrmacher V, Sandaltzopoulos R.Cancer immunotherapy: battling tumors with gene vaccines[J].Current Medicinal Chemistry Anti-IFNlammatory and Anti-allergy Agents, 2005, 4 ( 4 ) : 353-356.
  • 3Schirrmaeher V.T cell-mediated immunotherapy of metastases: state of the art in 2005[J].Expert Opin Biol Ther, 2005, 5 ( 8 ) : 1051-1068.
  • 4Schirrmaeher V, Griesbach A, Ahlert T.Antitumor effects of newcastle disease virus in vivo: local versus systemic effects[J].Int J Oncol, 2001, 18 (5) : 945-952.
  • 5殷君,王立芳,樊晓晖,梁莹,肖庆,宋德志,高灵茜,赖振屏.新城疫病毒对人NK细胞表达TRAIL的促进作用[J].肿瘤,2012,32(12):974-981. 被引量:6
  • 6Wilden H, Schlrrmaeher V, Fouruier P.Important role of interferon regulatory factor ( IRF ) -3 in the interferon response of mouse macrophages upon IFNection by Newcastle disease virus[J].Int J Oncol, 2011, 39 (2). 493-504.
  • 7Fournier P, Arnold A, Schirrmaeher V.Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus[J].J Buon, 2009, 14 ( 1 ) : 11-22.
  • 8Fournier P, Schirrmaeher V.Bispecifie antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future[J].Bio Drugs, 2013, 27 ( 1 ) : 35-53.
  • 9Brown D M.Cytolytic CD4 eeUs: direct mediators in infectious disease and malignaney[J].Cell Immunol, 2010, 262 ( 2 ) : 89-95.
  • 10Ashkenazi A, Pai R C, Fong S, et al.Safety and antitumor activity of recombinant soluble Apo2 ligand[J].The Journal of clinical investigation, 1999, 104 ( 2 ) : 155-162.

二级参考文献37

  • 1张沛怡,曹殿军,胡立华.新城疫病毒杀伤肝癌细胞的体外研究[J].中华肝脏病杂志,2005,13(6):467-468. 被引量:2
  • 2杜柏权,于源华,赵然,牛灵.Bcl-2/C-Raf双基因“敲低”抑制人结肠癌细胞增殖[J].中国生物化学与分子生物学报,2007,23(4):298-303. 被引量:1
  • 3Fujita N, Tsuruo T. Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis[J]. Biochem Biophys Res Commun, 1998, 246(2) : 484-488.
  • 4Elankumaran S, Rockemann D, Samal SK. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase- dependent pathways of cell death [ J]. J Virol, 2006, 80 (15) : 7522-7534.
  • 5Cheng EH, Kirsch D G, Clem R J, et al. Conversion of Bcl-2 to a bax-like death effector by Caspases [ J]. Science, 1997, 278 (5345) : 1966-1968.
  • 6Peeters BP, de Leeuw OS, Koch G, et al. Rescue of Newcastle disease virus from cloned cDNA : Evidence that cleavability of the fusion protein is a major determinant for virulence [ J]. J Virol, 1999, 73(6): 5001-5009.
  • 7Romer-Oberdorfer A, Mundt E, Mebatsion T, et al. Generation of recombinant lentogenic Newcastle disease virus from cDNA [J]. J Gen Virol,1999, 80(11): 2987-2995.
  • 8Krishnamurthy S, Huang Z H, Samal S K. Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: Expression of a foreign gene results in growth retardation and attenuation [J]. Virology, 2000, 278 (1):168-182.
  • 9Huang Z, Krishnamurthy S, Panda A, et al. High-level expression of a foreign gene from the most 3'- proximal locus of a recombinant Newcastle disease virus [J]. Gen Virol, 2001, 82 (Pt7):1729 - 1736.
  • 10Nakaya T, Cros J, Park M S, et al. Recombinant Newcastle disease virus as a vaccine vector [ J]. J Virol, 2001, 75 (23) : 11868-11873.

共引文献9

同被引文献33

  • 1岳惠芬,刘名光,梁新强,崔英,陈军.新城疫病毒Ⅳ系活疫苗辅助治疗鼻咽癌患者的临床效果观察研究[J].中华肿瘤防治杂志,2006,13(16):1219-1221. 被引量:8
  • 2文军宝,聂飚,姜泊.两种大肠癌细胞株小鼠肝转移模型的建立及比较[J].南方医科大学学报,2007,27(7):1044-1046. 被引量:10
  • 3Jemal A, Bray F, Center MM, et 81. Global cancer statistics [ J]. CA Cancer J Clin, 2011, 61(2) : 69-90.
  • 4Jones RP, Jackson R, Dunne DFJ, et al. Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver me- tastases [J]. Br J Surg, 2012, 99(4) : 477-486.
  • 5Lorence RM, Katubig BB, Reichard KW, et al. Complete regres- sion of human fibrosarcoma xenografts after local Newcastle disease virus therapy [J]. Cancer Res, 1994, 54(23) : 6017-6021.
  • 6Phuangsab A, Lorence RM, Reichard KW, et al. Newcastle dis- ease virus therapy of human tumor xenografts : Antitumor effects of local or systemic administration [ J]. Cancer Lett, 2001, 172 ( 1 ) : 27-36.
  • 7Lorence RM, Reichard KW, Katubig BB, et al. Complete regres- sion of human neuroblastoma xenografts in athymic mice after local Newcastle diseasevirus therapy [ J ]. J Natl Cancer Inst, 1994, 86 (16) : 1228-1233.
  • 8Lorence RM, Katubig BB, Reichard KW, et al. Complete regres- sion of human fibrosarcoma xenografts after local Newcastle disease virus therapy [J]. Cancer Res, 1994, 54(23): 6017-6021.
  • 9Stanziale SF, Fong Y. Novel approaches to cancer therapy using oncolytic virus [J]. Curt Mol Med, 2003, 3(1) : 61-71.
  • 10Song DZ, Liang Y, Fan XH, et al. TRAIL is involved in the tu- moricidal activity of mouse natural killer ceils stimulated by New- castle disease virus [ J ]. Anat Rec (Hoboken) , 20l 3,296 ( 10 ) : 1552-1560.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部